Physiologically based pharmacokinetic modeling with dichloromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humans
- 15 March 1991
- journal article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 108 (1) , 14-27
- https://doi.org/10.1016/0041-008x(91)90264-f
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Incorporation of in vitro enzyme data into the physiologically-based pharmacokinetic (PB-PK) model for methylene chloride: implications for risk assessmentToxicology Letters, 1988
- Physiologically based pharmacokinetics and the risk assessment process for methylene chlorideToxicology and Applied Pharmacology, 1987
- Metabolism of inhaled dihalomethanes in vivo: Differentiation of kinetic constants for two independent pathwaysToxicology and Applied Pharmacology, 1986
- A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humansToxicology and Applied Pharmacology, 1984
- Metabolism of inhaled brominated hydrocarbons: Validation of gas uptake results by determination of a stable metaboliteToxicology and Applied Pharmacology, 1982
- Modeling the uptake, metabolism and excretion of dichloromethane by manAihaj Journal, 1978
- Effect of dihalogenated methanes on the in vivo production of carbon monoxide and methane by ratsToxicology and Applied Pharmacology, 1977
- Predicting the carboxyhemoglobin levels resulting from carbon monoxide exposuresJournal of Applied Physiology, 1975
- Considerations of the physiological variables that determine the blood carboxyhemoglobin concentration in man.Journal of Clinical Investigation, 1965
- Partition of Carbon Monoxide and Oxygen Between Air and Whole Blood of Rats, Dogs and Men as Affected by Plasma pHJournal of Applied Physiology, 1957